SAM
SNDX icon

Simplify Asset Management’s Syndax Pharmaceuticals SNDX Stock Holding History

Simplify Asset Management’s Portfolio SNDX Stock Details SNDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-54,715
Closed -$1.15M – 170
2025
Q4 		$1.15M Buy
54,715
+26,210
+92% +$457K 0.02% 83
2025
Q3 		$439K Buy
28,505
+3,456
+14% +$45.2K 0.01% 106
2025
Q2 		$235K Sell
25,049
-122,736
-83% -$1.35M 0.01% 87
2025
Q1 		$1.82M Buy
147,785
+144
+0.1% +$2.03K 0.07% 52
2024
Q4 		$1.95M Buy
147,641
+25,456
+21% +$436K 0.1% 50
2024
Q3 		$2.35M Buy
122,185
+46,992
+62% +$971K 0.11% 49
2024
Q2 		$1.54M Sell
75,193
-144
-0.2% -$3.01K 0.1% 55
2024
Q1 		$1.79M Buy
75,337
+63,536
+538% +$1.42M 0.11% 59
2023
Q4 		$255K Sell
11,801
-864
-7% -$13.3K 0.02% 108
2023
Q3 		$184K Sell
12,665
-144
-1% -$2.72K 0.02% 120
2023
Q2 		$268K Buy
+12,809
New +$267K 0.04% 103

Other funds holding SNDX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
EP
Eversept Partners New York $1.9B AUM 121.13% 1-Year Est. Return
KCM
Kingdon Capital Management New York $911M AUM 51.11% 1-Year Est. Return
HRCM
Hood River Capital Management Palm Beach Gardens, Florida $9.98B AUM 145.42% 1-Year Est. Return

Simplify Asset Management's SNDX Position: Q1 2026 in Review

Simplify Asset Management sold out of Syndax Pharmaceuticals (SNDX) in Q1 2026, closing a stake of 54,715 shares — an estimated $1.15M sold.

Simplify Asset Management first reported a position in SNDX in Q2 2023 and held it in 11 quarters. The position peaked at $2.35M in Q3 2024. 247 funds tracked by Wall St. Rank hold SNDX as of Q1 2026.

  • Simplify Asset Management reported no remaining Syndax Pharmaceuticals position as of Q1 2026 after selling out during the quarter.
  • Simplify Asset Management sold 54,715 Syndax Pharmaceuticals shares in Q1 2026, an estimated $1.15M.
  • Simplify Asset Management first reported a position in Syndax Pharmaceuticals in Q2 2023 and held it in 11 quarters.
  • Simplify Asset Management's Syndax Pharmaceuticals position peaked at $2.35M in Q3 2024.
  • 247 funds tracked by Wall St. Rank held Syndax Pharmaceuticals as of Q1 2026.

Based on Simplify Asset Management's 13F filing for Q1 2026, filed 27 Apr 2026.